Jock meister - Gregg Popovich: Donald Trump
Jock meister - Gregg Popovich: Donald Trump ‘Xenophobic, Homophobic, Racist
NBA fans have heard some strong denunciations of President-elect Donald Trump from NBA coaches this week. Steve Kerr voiced concerns over his children’s reaction to Trump and Stan Van Gundy called Trump a “misogynist leader.” However, we hadn’t yet had anyone go biblical with his diatribe, until now.
Well, he almost went biblical.
“We are Rome,” said San Antonio Spurs Head Coach Gregg Popovich at the end of a fairly unhinged tirade. That tirade, captured by MySanAntonio.com, went on for several minutes and included insults to both Trump and his voters:
“The disgusting tenor and tone and all the comments [during Trump’s campaign] that have been xenophobic, homophobic, racist, misogynistic, and I live in a country where half the people ignored all that to elect someone.
“That’s the scariest part of the whole thing to me. Got nothing to do with the environment, Obamacare and all the other stuff. We live in a country that ignored all those values that we would hold our kids accountable for. They’d be grounded for years if they acted and said the things that’s been said in that campaign by Donald Trump.”
Far from done, Popovich then called Trump a bully. He said that Trump “used that fearmongering and all the comments, from Day 1, the race-baiting, with trying to make Barack Obama, our first black president, illegitimate. It leaves me wondering where I’ve been living, and with whom I’m living and the fact that people can just gloss that over. … Now we see that he’s already backing off immigration, Obamacare and other things, so was it a big fake? Which makes you feel that’s even more disgusting and cynical. That somebody would use that, to get the base that fired up to get elected.”
Not sure where Popovich got the idea that Trump has walked back all of his campaign promises. The two provisions of Obamacare that Trump mentioned wanting to keep happen to be the most popular provisions of the law, and neither has anything to do with denying you the right to choose your own coverage or hiking premiums to some ridiculous degree. In fact, Republicans, at least twice, have offered alternatives to Obamacare that included those provisions.
So, Trump has not come off his dime in any way. Popovich, however, has completely come undone. What’s different about Popovich’s rant, as opposed to Kerr’s and Van Gundy’s, is that instead of mostly confining his criticisms to Trump, “Pop” makes a point of going after Trump’s supporters.
Probably not a great move, considering Popovich lives and works in a state that Trump won by nearly ten percent.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...
Continue Reading
AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...
Continue Reading
History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...
Continue Reading
A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...
Continue Reading
Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....
Continue Reading
Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...
Continue Reading
Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...
Continue Reading
Top 5 Most Recently Viewed Articles
Fangzhou's AI-Driven Weight Management Innovation Unveiled In a landmark event in Beijing, the "Healthy China: AI + Weight Management" Innovation Symposium captured the attention of healthcare professionals and industry leaders. Hosted by Fangzhou Inc. (06086.HK), a pioneer in AI technologies for healthcare, the symposium underscored the importance of integrating...
Continue Reading
MGI Partners with Negedia for Enhanced Genomic Sequencing Understanding gene expression in the spatial context of tissues is a critical aspect of studying rare diseases and advancing precision medicine. Innovative technologies like high-throughput sequencing and spatial transcriptomics (STOmics) are revolutionizing our biological and molecular comprehension of diverse...
Continue Reading
SEO Builder Achieves Remarkable Growth Milestone SEO Builder, a prominent link-building agency based in the UK, is thrilled to announce that it has successfully surpassed the milestone of serving its 2,000th customer. Since launching in 2018, the company has achieved consistent growth, positioning itself as a trusted authority in the realm of local citation building....
Continue Reading
Gilbane Marks the Start of Lionsgate Studio Construction In a remarkable event, Gilbane Building officially commenced construction of Lionsgate Newark, a groundbreaking project that promises to reshape the film and television landscape in the region. The studio, spanning nearly 300,000 square feet, represents the first purpose-built facility in New Jersey tailored...
Continue Reading
Major Contract Awarded to KBR for Astronaut Health KBR has received an impressive contract valued at approximately $2.459 billion from NASA to bolster astronaut health and performance during space missions. This significant achievement showcases KBR's existing partnerships and expertise in supporting essential health and safety measures for astronauts, further emphasizing...
Continue Reading
